Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 04, 2019

SELL
$4.33 - $7.63 $56,290 - $99,190
-13,000 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$5.92 - $7.78 $76,960 - $101,140
13,000 New
13,000 $86,000

Others Institutions Holding CTSO

About Cytosorbents Corp


  • Ticker CTSO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 43,577,400
  • Market Cap $40.1M
  • Description
  • Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...
More about CTSO
Track This Portfolio

Track Papp L Roy & Associates Portfolio

Follow Papp L Roy & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Papp L Roy & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Papp L Roy & Associates with notifications on news.